Is Diabetes Associated with Shoulder Pain or Stiffness? Results from a Population Based Study

2009 ◽  
Vol 36 (2) ◽  
pp. 371-377 ◽  
Author(s):  
ANTONIA COLE ◽  
TIFFANY K. GILL ◽  
E. MICHAEL SHANAHAN ◽  
PATRICK PHILLIPS ◽  
ANNE W. TAYLOR ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Shoulder Pain ◽  
Population Based ◽  
Health Study ◽  
Population Based Study ◽  
Current Smoking ◽  
North West ◽  
Second Stage ◽  
The North ◽  
Hba1c Levels

Objectives.To assess the association of shoulder pain and/or stiffness and diabetes mellitus in a population based cohort.Methods.Participants were randomly recruited from the North West Adelaide Health Study, a longitudinal, population based study. In the second stage, 3128 participants were assessed for diabetes mellitus and shoulder complaints via questionnaires, the Shoulder Pain and Disability Index (SPADI), physical assessment, blood sampling for fasting plasma glucose, and HbA1c levels.Results.Overall, 682 (21.8%) participants experienced shoulder pain and/or stiffness and 221 participants (7.1%) fulfilled criteria for diabetes mellitus. Those with diabetes had a higher prevalence of shoulder pain and/or stiffness (27.9% vs 21.3%; p = 0.025), and poorer SPADI disability subscore (p = 0.01) and total SPADI score (p = 0.02). After controlling for age, sex, obesity, and current smoking, the prevalence of shoulder pain and/or stiffness did not differ significantly between those with diabetes and those without (OR 1.05, 95% CI 0.76–1.45), nor were there significant differences in the SPADI disability subscore (p = 0.39) or total SPADI score (p = 0.32) between the 2 groups. After adjustment for covariates, there was no association between higher levels of HbA1c and shoulder pain and/or stiffness (p > 0.8). Range of shoulder movement was significantly reduced in those with diabetes (p < 0.05).Conclusions.There is a higher prevalence of shoulder pain and/or stiffness in people with diabetes mellitus. The differences observed between those with diabetes and those without can largely be explained by the confounding factors of age, sex, obesity, and current smoking.

scholarly journals Treatment and survival of lymphoid malignancy in the north-west of England: a population-based study

1995 ◽  
Vol 72 (3) ◽  
pp. 757-765 ◽  
Author(s):  
JHAM Youngson ◽  
JM Jones ◽  
JG Chang ◽  
M Harris ◽  
SS Banergee
Keyword(s):  
Population Based ◽  
Lymphoid Malignancy ◽  
Population Based Study ◽  
North West ◽  
The North

scholarly journals Association between socio-demographic factors and diabetes mellitus in the north of Iran: A population-based study

2010 ◽  
Vol 2 (3) ◽  
pp. 154-157 ◽  
Author(s):  
Gholamreza Veghari ◽  
Mehdi Sedaghat ◽  
Hamidreza Joshaghani ◽  
Sed Ahmad Hoseini ◽  
Farhad Niknezad ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Demographic Factors ◽  
Population Based ◽  
Population Based Study ◽  
The North ◽  
North Of Iran ◽  
Socio Demographic Factors

Current Smoking is Associated with Incident Ankylosing Spondylitis — The HUNT Population-based Norwegian Health Study

2014 ◽  
Vol 41 (10) ◽  
pp. 2041-2048 ◽  
Author(s):  
Vibeke Videm ◽  
Adrian Cortes ◽  
Ranjeny Thomas ◽  
Matthew A. Brown
Keyword(s):  
Ankylosing Spondylitis ◽  
Adult Population ◽  
Population Based ◽  
Case Control ◽  
Sensitivity Analyses ◽  
Health Study ◽  
Hla B27 ◽  
Population Based Study ◽  
Current Smoking ◽  
Using Data

Objective.Smoking contributes to progression of ankylosing spondylitis (AS). Because smoking is also a risk factor for incident rheumatoid arthritis (RA) and psoriatic arthritis, our aim was to test whether smoking habits are associated with incident AS.Methods.Using data from the HUNT health study of the entire adult population of Nord-Trøndelag, Norway, participants in HUNT2 (1995–1997) and HUNT3 (2006–2008) were identified who reported a diagnosis of AS in HUNT3 but not in HUNT2 (n = 107). Incident AS cases were compared with AS-unaffected individuals (n = 35,278) in a case-control design. Participants with RA were excluded.Results.Present smoking was significantly associated with incident self-reported AS in logistic regression adjusted for potential confounders (OR 1.99, 95% CI 1.28–3.11, p = 0.002). Previous smoking (OR 1.15, 95% CI 0.66–2.02, p = 0.62) or total pack-years at HUNT2 (OR 1.01, 95% CI 0.99–1.04, p = 0.21) were not significant. The association with present smoking remained significant in various sensitivity analyses: including only cases with high probability of true AS diagnosis (OR 1.82, 95% CI 1.03–3.19, p = 0.04); including only cases with AS reported more than 3–5 years after HUNT2 (OR 2.34, 95% CI 1.09–5.03, p = 0.029), or including only participants genotyped for HLA-B27 (94 cases and 859 controls) adjusting for genotype (OR 1.79, 95% CI 1.04–2.85, p = 0.033). Hypertension was also significantly associated with incident AS (OR from 1.65 to 2.81).Conclusion.In the HUNT population-based study, incident AS was associated with current smoking and hypertension. If verified in further studies, this suggests that smoking should be discouraged in those at a higher AS risk, e.g., with a family history or carrying HLA-B27.

scholarly journals Polypill eligibility and equivalent intake in a Swiss population-based study

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Julien Castioni ◽  
Nazanin Abolhassani ◽  
Peter Vollenweider ◽  
Gérard Waeber ◽  
Pedro Marques-Vidal
Keyword(s):  
Enzyme Inhibitor ◽  
Large Fraction ◽  
Population Based ◽  
Cvd Risk ◽  
Population Based Study ◽  
Current Smoking ◽  
Swiss Population ◽  
Men Elderly ◽  
Multivariable Adjustment

AbstractThe polypill has been advocated for cardiovascular disease (CVD) management. The fraction of the population who could benefit from the polypill in Switzerland is unknown. Assess (1) the prevalence of subjects (a) eligible for the polypill and (b) already taking a polypill equivalent; and (2) the determinants of polypill intake in the first (2009–2012) and second follow-ups (2014–2017) of a population-based prospective study conducted in Lausanne, Switzerland. The first and the second follow-ups included 5038 and 4596 participants aged 40–80 years, respectively. Polypill eligibility was defined as having a high CVD risk as assessed by an absolute CVD risk ≥ 5% with the SCORE equation for Switzerland and/or presenting with CVD. Four polypill equivalents were defined: statin + any antihypertensive with (A) or without (B) aspirin; statin + calcium channel blocker (CCB) (C); and statin + CCB + angiotensin-converting enzyme inhibitor (D). The prevalence of polypill eligibility was 20.6% (95% CI 19.5–21.8) and 27.7% (26.5–29.1) in the first and second follow-up, respectively. However, only around one-third of the eligible 29.5% (95% CI 26.7–32.3) and 30.4% (27.9–33.0) respectively, already took the polypill equivalents. All polypill equivalents were more prevalent among men, elderly and in presence of CVD. After multivariable adjustment, in both periods, male gender was associated with taking polypill equivalent A (OR: 1.93; 95% CI 1.45–2.55 and OR: 1.67; 95% CI 1.27–2.19, respectively) and polypill equivalent B (OR: 1.52; 95% CI 1.17–1.96 and OR: 1.41; 95% CI 1.07–1.85, respectively). Similarly, in both periods, age over 70 years, compared to middle-age, was associated with taking polypill equivalent A (OR: 11.71; CI 6.74–20.33 and OR: 9.56; CI 4.13–22.13, respectively) and equivalent B (OR: 13.22; CI 7.27–24.07 and OR: 20.63; CI 6.51–56.36, respectively). Former or current smoking was also associated with a higher likelihood of taking polypill equivalent A in both periods. A large fraction of the population is eligible for the polypill, but only one-third of them actually benefits from an equivalent, and this proportion did not change over time.

scholarly journals Depression and health risk factors in the North West Adelaide Health Study

2006 ◽  
Vol 18 (6) ◽  
pp. 304-305
Author(s):  
N Potts ◽  
D Wilson ◽  
A Taylor ◽  
T Gill ◽  
G Schrader ◽  
...  
Keyword(s):  
Risk Factors ◽  
Health Risk ◽  
Health Study ◽  
Health Risk Factors ◽  
North West ◽  
The North

scholarly journals Colonoscopy and Flexible Sigmoidoscopy Practice Patterns in Ontario: A Population-Based Study

2007 ◽  
Vol 21 (7) ◽  
pp. 431-434 ◽  
Author(s):  
Susan E Schultz ◽  
Chris Vinden ◽  
Linda Rabeneck
Keyword(s):  
Flexible Sigmoidoscopy ◽  
Practice Patterns ◽  
Age Groups ◽  
Population Based ◽  
Insurance Plan ◽  
Ontario Health Insurance Plan ◽  
Population Based Study ◽  
The North ◽  
General Surgeons ◽  
Statistics Canada

OBJECTIVE: To conduct a population-based study on the provision of large bowel endoscopic services in Ontario.METHODS: Data from the following databases were analyzed: the Ontario Health Insurance Plan, the Institute for Clinical Evaluative Sciences Physicians Database and Statistics Canada. The flexible sigmoidoscopy and colonoscopy rates per 10,000 persons (50 to 74 years of age) by region between April 1, 2001, and March 31, 2002, were calculated, as well as the numbers and types of physicians who performed each procedure.RESULTS: In 2001/2002, a total of 172,108 colonoscopies and 43,400 flexible sigmoidoscopies were performed in Ontario for all age groups. The colonoscopy rate was approximately five times that of flexible sigmoidoscopy; rates varied from 463.1 colonoscopies per 10,000 people in the north to 286.8 colonoscopies per 10,000 people in the east. Gastroenterologists in all regions tended to perform more procedures per physician, but because of the large number of general surgeons, the total number of procedures performed by each group was almost the same.CONCLUSION: Population-based rates of colonoscopies and flexible sigmoidoscopies are low in Ontario, as are the procedure volumes of approximately one-quarter of physicians.

Sign in / Sign up

Export Citation Format

Share Document